El Hadri K, Smith R, Duplus E, El Amri C
Effect of Semaglutide on Coronary Atherosclerosis Progression in Patients With Type II Diabetes: Rationale and Design of the Semaglutide Treatment on Coronary Progression Trial
Week 1-2: 0.5mg to 1mg once daily Week 3-4: 1mg once daily Week 5 onward: 1mg to 1.5mg once daily This gradual approach lets researchers assess tolerance
Reeves, Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges
206,347 In another study, treatment of primary mouse chondrocytes with liraglutide reduced the mRNA expression levels of iNOS, MMP-13, and ADAMTS5, leading to a decrease in the secretion of inflammatory markers, including NO, prostaglandin E, and IL-6